September 3, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of August 2021. This is based on the website’s 201,568 pageviews for the month.



September 1, 2021 — The world’s first feasibility study has found that drones can be used to deliver life-saving defibrillators to people with suspected cardiac arrest in the community.


September 1, 2021 — The STOPDAPT-2 ACS trial does not support the use of one month of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) patients undergoing stent implantation. That was the finding of late-breaking research presented in a Hot Line session at European Society of Cardiology (ESC) Congress 2021.[1]

American Society of Nuclear Medicine 2021 Scientific Sessions

September 1, 2021 – The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart attack or stroke in patients with atrial fibrillation (AF) who undergo transcatheter aortic valve replacement (TAVR), according to a large-scale international study led by Mount Sinai.  

September 1, 2021 — Stereotaxis and Shanghai Microport EP Medtech Co., Ltd. announced a broad collaboration to advance technology innovation and commercial adoption of robotics in electrophysiology (EP) in China.

September 1, 2021 — University of South Australia researchers have designed a computer vision system that can automatically detect a tiny baby’s face in a hospital bed and remotely monitor its vital signs from a digital camera with the same accuracy as an electrocardiogram machine.

Using artificial intelligence-based software to detect human faces is now common with adults, but this is the first time that researchers have developed software to reliably detect a premature baby’s face and skin when covered in tubes, clothing, and undergoing phototherapy.

Deep integration of Epsilon strain echo software with a major CVIS vendor
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      One of the trends in cardiovascular information system (CVIS) and radiology PACS at the Healthcare Information Management Systems Society (HIMSS) 2021 conference was the deeper integration of third-party image analysis software and artificial intelligence (AI) into these systems. This eliminates software sitting on top of the CVIS or PACS, separate logins or needing to us a different screen or manually transferring information from the third-party app in into the final report.

      A good example of this was Siemens Healthineers, which demonstrated a deep integration with Epsilon Imaging’s echocardiography strain imaging analysis software. The integration eliminates the need for a separate login to the software, and automated quantification and images are carried over directly into the syngo echo report.

      Strain can be used to assess cardiac function more precisely than regular cardiac ultrasound exams. It has grown in its use for cardio-oncology programs, assessing a baseline cardiac function and the. Performing serial exams over the course of a cancer patient’s chemotherapy. Strain has seen growing interest and has been a hot topic the past couple years at the American Society of Echocardiography (ASE) meeting. Interest also has expanded greatly recently with reimbursement now available in the U.S.

      Siemens said there also has been increased interest in strain this past year because it can show early indicators of cardiac issues in COVID-19 patients and can be used to help monitor COVID myocarditis patients.
       

      Related Strain Echo and HIMSS Content:

      VIDEO: An Overview of Echo Strain Imaging — Interview with Marielle Scherrer-Crosbie, M.D.

      Global Longitudinal Strain Echo Offers Early Detection of Cardiotoxicity Heart Damage From Chemotherapy

      Strain Imaging Improves Cardiac Surveillance of Certain Breast Cancer Patients

      VIDEO: Assessing Cardiotoxicity Response With Cardio-Oncology Echo Imaging — Interview with Federico Asch, M.D.

      Assessing Cardiotoxicity Due to Cancer Therapy

       

      Advances in CVIS and Enterprise iImaging at HIMSS 21

      VIDEO: Cardiology AI Aggregates Patient Data and Enables Interactive Risk Assessments

      Photo Gallery of New Technologies at HIMSS 2021

      VIDEO: Importance of Body Part Labeling in Enterprise Imaging — Interview with Alex Towbin, M.D., at HIMSS21

      VIDEO: Coordinating Followup for Radiology Incidental Findings — Interview with David Danhauer, M.D., at HIMSS21

      Recent Videos View all 660 items

      January 30, 2025

      On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

      During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

      Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
       

      Company Profile

      The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

      For more information, visit optum.com.

      January 07, 2025

      On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

      Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

      In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

      Learning Objectives

      * Understand basic mechanisms of contrast induced kidney injury.
      * Determine incidence of disease along with long term patient and economic implications.
      * Review risk factors determining higher risk populations.
      * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
      * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

      Dr. Aditya Sharma
      Dr Aditya Sharma

      Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

      About ACIST

      Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

      January 01, 2025

      Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

      The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

      Learning Objectives

      By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

      • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

      • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

      • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

      Featured Speakers

      headshot

      Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

      Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



      headshot

      Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

      Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

      About ACIST

      Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

      January 24, 2025

      Behavioral science is being applied in unique ways for enterprise-imaging product design.

      Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

      In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

      Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

      By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

      Learning Objectives

      • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

      • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

      • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

      Featured Speakers

      James Stinnett

      James Stinnett, Behavioral Scientist, Change Healthcare

      James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

      Dr. Barry Bertolet

      Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

      Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

      About Change Healthcare

      Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

      Sponsored Videos View all 46 items

      Cardiovascular Ultrasound | July 20, 2022

      Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

      Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

      Cardiovascular Ultrasound | July 07, 2022

      Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

      Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

      *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

      Cardiovascular Ultrasound | June 14, 2022

      The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

      Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

      Cardiovascular Ultrasound | May 31, 2022

      Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

      Conference Coverage View all 467 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Cath Lab View all 316 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Cardiac Imaging View all 289 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Cardiac Diagnostics View all 78 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      EP Lab View all 83 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      Information Technology View all 177 items

      Cardiovascular Clinical Studies | July 30, 2024

      As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

      As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

      His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

      Related content:

      DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

      DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

       

      HIMSS | July 24, 2024

      Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

      Find more HIMSS24 conference coverage here

      A New Partnership for Growth

      Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

      Exciting New Features at HIMSS24

      At HIMSS2024, with this new collaboration comes new features, including:

      Related content:

      Find more HIMSS24 conference coverage here

      HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

      Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Information Technology | May 17, 2023

      HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

       

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

       

       

      Information Technology | May 11, 2023

      Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

      Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

      Find more HIMSS23 coverage here

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      Related Digital Transformation Content:

      Robocath Launches New Robotic Platform R-One+

      VIDEO: Using Maturity Models to Measure Digital Health

      VIDEO: Moving Digital Transformation Forward in Healthcare

      VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

      VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

      VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

      New ACC President Defines Priorities for Year Ahead

      Health That Connects + Tech That Cares at HIMSS 2023

      ACC22: Transforming Cardiovascular Care

      August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA) Occluder FDA IDE trial showed the Amulet was superior for the primary endpoint of LAA closure and noninferior for the primary endpoints of safety and effectiveness versus the first generation Boston Scientific Watchman occluder. A new version of the Watchman was released in 2020 and was not part of this trial.

      AI for cardiology data aggregation from MediCardia at HIMSS 2021
      Video Player is loading.
      Current Time 0:00
      Duration 0:00
      Loaded: 0%
      Stream Type LIVE
      Remaining Time 0:00
       
      1x
        • Chapters
        • descriptions off, selected
        • captions off, selected

          The vendor MediCardia demonstrated smart software to aggregate cardiology patient data from numerous locations into one place at the 2021 Healthcare Information Management Systems Society (HIMSS) conference. This enables one dashboard view of the patient's relevant cardiac history, prior exams, imaging, ECGs, labs and procedures. It also uses artificial intelligence (AI) to pull key data elements about the patient to automatically create risk assessments based on current guidelines in a graphical format.

          The interactive system also allows the cardiologist to adjust parameters in the patient risk score to immediately show the patient any impact on their score. This includes if they stopped smoking, began taking statins, etc. The dynamic graphics of the system are also designed to be more engaging with a patient during consultations, rather than plain white pages of reports.

          MediCardia HeartChart is a cardiology-focused virtual care platform that serves as a unified and common interface for EHRs and remote technologies including wearables, consumer home medical devices, and implanted cardiac rhythm devices. 

          Related HIMSS CVIS and PACS Content:

          Read about more advances in PACS and enterprise imaging at HIMSS 21.

          VIDEO: Example of Epsilon Strain Imaging Deep Integration With Siemens CVIS

          Photo Gallery of New Technologies at HIMSS 2021

          VIDEO: Importance of Body Part Labeling in Enterprise Imaging — Interview with Alex Towbin, M.D.

          VIDEO: Coordinating Followup for Radiology Incidental Findings — Interview with David Danhauer, M.D.

          Recent Videos View all 660 items

          January 30, 2025

          On July 16, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." 

          During the webinar, Omer Schalit–Cohen, chief product officer at Optum’s Healthcare Enterprising Imaging business unit, addressed optimizing workflow and efficiencies in the cardiovascular imaging department.  In the presentation, Cohen examines how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures.

          Schalit–Cohen is the chief product officer at Optum’s Healthcare Enterprising Imaging business unit. With more than 20 years of experience in innovation, he is an expert in the Imaging’s department complex workflows and has been instrumental in driving market leading solutions that have significantly enhanced patient care and department’s efficiency. as well as customer satisfaction.
           

          Company Profile

          The webinar is sponsored by Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 215,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group.

          For more information, visit optum.com.

          January 07, 2025

          On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

          Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

          In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

          Learning Objectives

          * Understand basic mechanisms of contrast induced kidney injury.
          * Determine incidence of disease along with long term patient and economic implications.
          * Review risk factors determining higher risk populations.
          * Evaluate device strategy in modern era to mitigate risk and promote procedural efficiency and safety.
          * Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 

          Dr. Aditya Sharma
          Dr Aditya Sharma

          Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

          About ACIST

          Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

          January 01, 2025

          Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

          The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

          Learning Objectives

          By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

          • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.

          • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.

          • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

          Featured Speakers

          headshot

          Dr. Matheen A. Khuddus, Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab, HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

          Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.



          headshot

          Dr. Darshan Doshi, Director of Complex Coronary Artery Disease, Massachusetts General Hospital, Boston, Mass.

          Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

          About ACIST

          Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

          January 24, 2025

          Behavioral science is being applied in unique ways for enterprise-imaging product design.

          Behavioral science is the study of human behavior. It’s a mix of psychology, sociology, social and cultural anthropology, and economics. Using a data-driven, human-centered approach, behavioral science helps uncover what people have done in the past and tries to predict — and often change — how they’ll behave in the future.

          In this webinar, leading healthcare experts will discuss how observation, interviews, and experimentation can help the industry form a better understanding of current customer needs and pain points within cardiovascular imaging. Having clinicians involved in the product-design process has led to the complete rearchitecting of a next-generation hemodynamics solution.

          Using a real-world scenario, we’ll share a clinician’s experience working with behavioral science and product-development teams, provide an understanding of how they’re using hemodynamics today, and get their thoughts on the future of imaging and hemodynamics.

          By listening to key stakeholders, new features can be brought to market that will have a notable impact on the way health systems operate. By building better products, we can help improve patient outcomes and ultimately transform the healthcare industry — one behavior at a time.

          Learning Objectives

          • How a next-generation hemodynamics system has implemented 19 user-centric concepts and undergone iterative testing with healthcare providers.

          • How physicians, technicians, nurses and administrators are providing their expertise to bring new features to market that will have a notable impact on the way health systems operate.

          • What a next-generation hemodynamics system can do to keep pace with new technology innovations in cardiovascular care and increasing clinical demands.

          Featured Speakers

          James Stinnett

          James Stinnett, Behavioral Scientist, Change Healthcare

          James Stinnett is an experienced researcher with a background in product, UX, and behavioral science. He joined Change Healthcare three years ago and is currently a researcher on the behavioral science team.

          Dr. Barry Bertolet

          Dr. Barry Bertolet, Interventional Cardiologist and Director of Cardiac Catheterization Laboratory, North Mississippi Medical Center

          Dr. Barry Bertolet champions the education of physicians and patients throughout the region and has participated in numerous research trials exploring early detection and treatment of cardiovascular diseases. He is a founding member of the Mississippi Health Care Alliance, an organization which has developed the nation’s first statewide system of care for both heart attack and stroke. He is also board certified by the American Board of Internal Medicine in cardiovascular disease, internal medicine and interventional cardiology.

          About Change Healthcare

          Change Healthcare is a leading independent healthcare technology company, focused on insights, innovation and accelerating the transformation of the healthcare system through the power of the Change Healthcare platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

          Sponsored Videos View all 46 items

          Cardiovascular Ultrasound | July 20, 2022

          Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

          Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

          Cardiovascular Ultrasound | July 07, 2022

          Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

          Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

          *External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

          Cardiovascular Ultrasound | June 14, 2022

          The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

          Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

          Cardiovascular Ultrasound | May 31, 2022

          Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

          Conference Coverage View all 467 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Cath Lab View all 316 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Cardiac Imaging View all 289 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Cardiac Diagnostics View all 78 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          EP Lab View all 83 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Information Technology View all 177 items

          Cardiovascular Clinical Studies | July 30, 2024

          As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

          As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

          His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

          Related content:

          DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

          DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

           

          HIMSS | July 24, 2024

          Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.

          Find more HIMSS24 conference coverage here

          A New Partnership for Growth

          Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.

          Exciting New Features at HIMSS24

          At HIMSS2024, with this new collaboration comes new features, including:

          Related content:

          Find more HIMSS24 conference coverage here

          HIMSS Launches Modernized Infrastructure Adoption Model to Support Global Digital Health Transformation

          Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Information Technology | May 17, 2023

          HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

           

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

           

           

          Information Technology | May 11, 2023

          Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

          Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor.  Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU).  She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.  Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.  

          Find more HIMSS23 coverage here

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          Related Digital Transformation Content:

          Robocath Launches New Robotic Platform R-One+

          VIDEO: Using Maturity Models to Measure Digital Health

          VIDEO: Moving Digital Transformation Forward in Healthcare

          VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions

          VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare

          VIDEO: A Look at Cybersecurity and How Healthcare is at Risk

          New ACC President Defines Priorities for Year Ahead

          Health That Connects + Tech That Cares at HIMSS 2023

          ACC22: Transforming Cardiovascular Care

          Subscribe Now